Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
CTR20262522 HRN77 Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262522 clinical trial report covering HRN77, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262488 LPM-3770164 Huntington Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262488 clinical trial report covering LPM-3770164, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07672756 PJ-008 Phenylketonurias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672756 clinical trial report covering PJ-008, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07673068 Recombinant Hepatitis B Therapeutic Vaccine(Grand Theravac Life) Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673068 clinical trial report covering Recombinant Hepatitis B Therapeutic Vaccine(Grand Theravac Life), Phase 1, endpoints, sponsor, geography, readou
Read →
Latest Hotspot
8 min read
NCT07673601 ARGX-119 Herpesviridae Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673601 clinical trial report covering ARGX-119, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07673900 Semaglutide (Terrestrial) Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673900 clinical trial report covering Semaglutide (Terrestrial), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07674615 Sacituzumab govitecan-hziy Primary peritoneal carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674615 clinical trial report covering Sacituzumab govitecan-hziy, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07674693 Retreatment Rhenium Liposome Metastatic Malignant Neoplasm to the Leptomeninges Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674693 clinical trial report covering Retreatment Rhenium Liposome, Phase 1, endpoints, sponsor, geography, readout timing and development white space
Read →
Latest Hotspot
8 min read
NCT07672717 Cabotegravir sodium HIV Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672717 clinical trial report covering Cabotegravir sodium, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07674966 Atropine Sulfate Myopia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674966 clinical trial report covering Atropine Sulfate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07672483 IL-12 (SYTE) Refractory Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672483 clinical trial report covering IL-12 (SYTE), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07676357 RFUS-949 Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676357 clinical trial report covering RFUS-949, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
419
420
421
422
423
>>
1222
>